RECURRENT CERVICAL CANCER
Clinical trials for RECURRENT CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CERVICAL CANCER trials appear
Sign up with your email to follow new studies for RECURRENT CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo shows promise for Tough-to-Treat cervical cancer
Disease control CompletedThis study tested a combination of an immunotherapy drug (anti-PD-1) and a chemotherapy drug (albumin-bound paclitaxel) in 27 patients whose cervical cancer had returned or worsened after standard treatment. The goal was to see if the combination could shrink tumors and help pati…
Matched conditions: RECURRENT CERVICAL CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 12:06 UTC
-
New hope for advanced cervical cancer? eribulin drug trial shows promise
Disease control CompletedThis study tested the chemotherapy drug eribulin in 32 people with advanced or recurrent cervical cancer that had spread or come back. The goal was to see if the drug could stop or slow tumor growth. Researchers measured how long patients lived without the cancer getting worse an…
Matched conditions: RECURRENT CERVICAL CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 22, 2026 13:50 UTC